Revvity Signals 2024: Empowering Scientific Innovation and Collaboration

Click here to watch a recap video of 2024

As 2024 has come to an end, we're taking a moment to look back on an incredible year. It was a year packed with milestones: transformative product launches, collaborative ventures, comprehensive software solutions, and impactful thought leadership. We stayed focused on one goal— empowering scientists with a comprehensive suite of enterprise scientific solutions. 

To our customers, we hear you. At Revvity Signals, your direct feedback and aspirations fuels our innovation and motivation to create breakthrough solutions. Here's a recap at solutions we designed, adapted, and introduced over the last year and how we’re building even more momentum for a brighter, more connected future.
 

Transforming Chemistry with Signals™ ChemDraw

In the scientific industry, we are aware of the challenges chemists face in managing, searching, and presenting their complex chemistry data. With increasing needs for fast, complex molecule drawings and seamless collaboration, digital tools support laboratory needs to drive clarity, innovation, and impactful discoveries. 

Last year, we introduced Signals ChemDraw, the next-generation software, supporting FAIR data principles and addressing the needs of chemists to safely and confidently streamline workflows, search and find chemical drawings, and repurpose existing visuals effortlessly.  

The new cloud native Signals ChemDraw leverages web capabilities to give users best in class tools at their fingertips: 

  • Secured access with a simple browser from their preferred device 
  • Core editing and chemical drawing capabilities online
  • Oligomer representation with HELM, the scientific standard for macromolecules
  • Search Word, Excel, PowerPoint files, and Signals™ Notebook to find chemical drawing from their experiments and within their project documents to directly reuse them
  • Efficient organization of chemistry data with collections
  • Engaging communication of complex chemical concepts
  • Collaborative work with live document updates
  • The advantage of constant feature updates directly deployed by Revvity Signals
     

Signals ChemDraw is a solution that turns chemical ideas into actionable knowledge with speed and eye-catching detail to make your research shine. You’re solving complex scientific challenges; we’re streamlining your software and workflows to meet these needs with ease.
 

Accelerating Clinical Insights with Signals™ Clinical

At the heart of every product idea and launch is a simple goal: to address cutting-edge scientific needs smoother, faster, and more intuitively, with solutions that reduce friction and enhance productivity.

Designed to integrate effortlessly into your daily work, Revvity Signals launched Signals Clinical, a new solution that streamlines clinical data workflows and eliminates delays caused by outdated, manual processes. 

By centralizing clinical data, automating refreshes, and enabling custom analytics, Signals Clinical empowers teams to access data and insights faster than ever.

The platform offers a range of tools, including a library of configurable workflows that streamline clinical data review and medical review, integrated collaboration, and automated data tracking, all aimed at accelerating decision-making for clinical needs.
 
With Signals Clinical, Revvity Signals addressed a critical pain point— delays in accessing and analyzing data— giving users real-time, self-service access to deliver deeper insights and transform clinical development. 
 

Redefining Sponsor-CRO Collaboration with Signals™ Synergy 

For scientists collaborating across the sponsor/CRO partnership, we understood your challenges and pain points and to address these we have proudly launched Signals Synergy.  Signals Synergy is a game-changing platform designed to strengthen shared workflows and the collaboration between pharma and biotech sponsors and their CRO partners. 

Built to meet the demands of modern drug discovery, Signals Synergy integrates seamlessly with our other products, Signals Notebook and Signals Research Suite, enabling effortless information exchange, scientifically minded project management, and expanded system-level CRO capabilities.

Signals Synergy addresses real challenges that our clients face in outsourcing drug discovery research by rationalizing data sharing, automating administrative workflows, and keeping your intellectual property safe.  Our goal is to maintain a user-friendly experience.  With modern technology, integrating a new product should be as easy as downloading a new app on your phone.  


Mobilizing the Future of R&D with New Modalities 

In today’s evolving drug discovery landscape, where new therapeutic possibilities are on the edge of exploration and development, we understand the challenges researchers face in their day-to-day labs. Throughout 2024, the Revvity Signals team narrowed in on addressing the complex topic of pioneering new modalities. 

By embracing a multimodality approach, we’re bridging the gap in diverse therapeutic strategies—whether small molecules, biologics, RNA-based therapies, or complex combinations like antibodies. We remain committed to helping scientists navigate complexity and push the boundaries of what’s possible, including tackling targets once considered “undruggable.” 
 
Revvity Signals Software solutions are here to support the shift toward new and diverse modalities in drug discovery and research development. No matter your modality, whether in chemistry or large molecule, we offer tools that explore fresh approaches to make meaningful progress in today’s multimodal world.


Strengthening Capabilities with Advanced Formulation Science

From enhanced calculation functionalities and advanced variation tables to more flexible data sorting and streamlined table publication, Revvity Signals has significantly upgraded our data-table-focused capabilities to empower formulation scientists, in Drug Discovery, Chemicals & Materials, and Food, Flavor, & Fragrance, to innovate more effectively. Recognizing the critical role data tables play in formulation, we dedicated substantial resources to not only expand features for data optimization but also elevate the user experience. 


Leveraging Innovation with our AI Roadmap

We are continuing our AI journey and embedding and integrating the power of AI into our solutions. Our AI strategy streamlines workflows and ensures robust data security and is built on three pillars:

  • Leveraging generative AI and LLM’s (large language models) to streamline workflows
  • Accelerating research with specialized science-based AI integrations
  • Unifying and modelling data to be fully AI-ready

We provide access to cutting-edge tools enhanced by AI, allowing scientists to shift their focus to innovation and away from repetitive mundane tasks. By empowering human capabilities with smart technology and machine intelligence, our AI-driven software continues to empower researchers to accelerate the pace of drug discovery, clinical research, and product commercialization.


Harnessing Scientific Discovery, Research, and Development with Signals Research Suite ™

Having to bounce between different software and platforms is time consuming and requires manual connection across databases. Revvity Signals understood the need and developed a solution to combat this common laboratory frustration, by launching the most comprehensive research SaaS solution, Signals Research Suite. Signals Research Suite helps keep your teams, tools, and data connected in a single platform so you can get your life-changing discoveries and products to market sooner.

In 2024, we continued to build out this solution with web based Spotfire® access and improved file handling and other AI-driven technology. When it comes to drug discovery, we understand that time is precious. Our software helps scientists avoid repetitive administrative tasks so they can focus on scientific innovation. Digital transformation is at the core of modern labs, taking strategic strides to optimize production, improve safety, and elevate discovery breakthroughs.

As the only source of Spotfire for scientific R&D and clinical development, Revvity Signals empowers scientific teams and organizations with quick access to data and insights, in real-time.


Full Speed Ahead for 2025

In many ways, 2024 set the stage for significant progress, fueled by new product launches and a commitment to turning bold ideas into reality. We are listening to your needs and responding with breakthrough solutions. Now, as we gear up for 2025, our efforts remain clear: continue to deliver the most comprehensive suite of enterprise scientific software solutions, providing scientists with the necessary tools to drive actionable insights.

We're energized by what lies ahead and ready to continue pushing the boundaries of what's possible for the scientific community in 2025 and beyond!


To learn more and stay informed, you can connect with us in a few ways:

If you want to learn more about any Revvity Signals solution you can contact us here.

For more resources, tailor by solutions, topics, and products in our Content Library

To see our solutions in actions via our interactive demos or request a demo.

To gain deeper insights join our Revvity Signals Connect webinar series and pick a series that’s tailored to you. 

Through our Ideas Portal, you can share, engage with, and track product improvement ideas. Keep inspiring us by sharing your ideas and aspirations and we commit to working to find solutions that fulfill your needs.
 

node:field_display_author:entity:field_person_image:entity:image:alt
Mary Donlan, Ph.D.
Executive Director, Product Marketing

Mary Donlan, Ph.D., leads the Product Marketing team at Revvity Signals. She has 20+ years of Life science enterprise software experience in marketing, business development and field applications. She holds a Ph.D. in Chemistry from University of Pennsylvania.